US Patent Issued to MINDRANK AI on April 7 for "Aryl ether-substituted heterocyclic compounds as glpir agonists" (Chinese Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,249, issued on April 7, was assigned to MINDRANK AI LTD. (Hangzhou, China). "Aryl ether-substituted heterocyclic compounds as glpir agonist... Read More

US Patent Issued to ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY on April 7 for "Substituted pyrimidine compounds as multifunctional radical quenchers and their uses" (American, French Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,250, issued on April 7, was assigned to ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (Scottsdale, Ariz.). "Substituted py... Read More

US Patent Issued to GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION on April 7 for "Amidines and amidine analogs for the treatment of bacterial infections and potentiation antibiotics" (Georgia, North Carolina Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,251, issued on April 7, was assigned to GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION INC. (Atlanta). "Amidines and amidine analogs for the ... Read More

US Patent Issued to DISARM THERAPEUTICS on April 7 for "Inhibitors of SARM1" (British, American Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,252, issued on April 7, was assigned to DISARM THERAPEUTICS INC. (Indianapolis). "Inhibitors of SARM1" was invented by Robert Owen Hughes (... Read More

US Patent Issued to LYNK PHARMACEUTICALS on April 7 for "Benzamides of pyrazolylamino-pyrimidinyl derivatives, and compositions and methods thereof" (Chinese, American Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,253, issued on April 7, was assigned to LYNK PHARMACEUTICALS Co. LTD. (Hangzhou, China). "Benzamides of pyrazolylamino-pyrimidinyl derivati... Read More

US Patent Issued to CRYSTAL PHARMACEUTICAL (SUZHOU) on April 7 for "Crystal form of Resmetirom, preparation method therefor, and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,254, issued on April 7, was assigned to CRYSTAL PHARMACEUTICAL (SUZHOU) Co. LTD. (Suzhou, China). "Crystal form of Resmetirom, preparation ... Read More

US Patent Issued to Hoffmann-La Roche on April 7 for "Heteroaryl-substituted imidazole derivatives" (Chinese, Swiss Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,255, issued on April 7, was assigned to Hoffmann-La Roche Inc. (Little Falls, N.J.). "Heteroaryl-substituted imidazole derivatives" was inv... Read More

US Patent Issued to Merck Patent on April 7 for "Composition for organic electronic devices" (German Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,256, issued on April 7, was assigned to Merck Patent GmbH (Darmstadt, Germany). "Composition for organic electronic devices" was invented b... Read More

US Patent Issued to LG DISPLAY, LT MATERIALS on April 7 for "Heterocyclic compound, organic light emitting device including the same and composition for organic layer of organic light emitting device" (South Korean Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,257, issued on April 7, was assigned to LG DISPLAY Co. LTD. (Seoul, South Korea) and LT MATERIALS Co. LTD. (Yongin-si, South Korea). "Heter... Read More

US Patent Issued to Tolremo Therapeutics on April 7 for "Heterocyclic derivatives, pharmaceutical compositions and their use in the treatment or amelioration of cancer" (Swiss Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,258, issued on April 7, was assigned to Tolremo Therapeutics AG (Muttenz, Switzerland). "Heterocyclic derivatives, pharmaceutical compositi... Read More

• ««
• «
• 56158
• 56159
• 56160
• 56161
• 56162
• 56163
• 56164
• 56165
• 56166
• 56167
• »
• »»